Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 49% ± 19% | |
type I pneumocyte | 11 studies | 26% ± 10% | |
mesothelial cell | 8 studies | 36% ± 12% | |
retinal pigment epithelial cell | 3 studies | 33% ± 6% | |
abnormal cell | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 31% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 5255.81 | 328 / 328 | 91% | 52.47 | 162 / 178 |
ovary | 99% | 5077.46 | 179 / 180 | 86% | 30.92 | 369 / 430 |
liver | 96% | 2553.73 | 218 / 226 | 88% | 24.63 | 359 / 406 |
brain | 96% | 10429.36 | 2541 / 2642 | 84% | 29.91 | 589 / 705 |
kidney | 99% | 3006.76 | 88 / 89 | 81% | 15.18 | 727 / 901 |
stomach | 80% | 18152.72 | 286 / 359 | 83% | 29.51 | 236 / 286 |
lung | 97% | 6612.03 | 560 / 578 | 51% | 11.77 | 584 / 1155 |
uterus | 86% | 5086.54 | 146 / 170 | 42% | 8.90 | 192 / 459 |
intestine | 40% | 952.10 | 383 / 966 | 81% | 23.61 | 426 / 527 |
eye | 0% | 0 | 0 / 0 | 81% | 6.11 | 65 / 80 |
esophagus | 10% | 142.79 | 144 / 1445 | 58% | 35.89 | 106 / 183 |
bladder | 0% | 0 | 0 / 21 | 36% | 5.02 | 181 / 504 |
adipose | 34% | 2011.68 | 408 / 1204 | 0% | 0 | 0 / 0 |
skin | 1% | 9.06 | 14 / 1809 | 22% | 2.41 | 102 / 472 |
tonsil | 0% | 0 | 0 / 0 | 22% | 2.17 | 10 / 45 |
lymph node | 0% | 0 | 0 / 0 | 17% | 2.89 | 5 / 29 |
thymus | 0% | 0 | 0 / 653 | 14% | 2.40 | 87 / 605 |
blood vessel | 12% | 194.54 | 158 / 1335 | 0% | 0 | 0 / 0 |
heart | 8% | 182.05 | 68 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 7% | 149.64 | 64 / 929 | 0% | 0 | 0 / 0 |
breast | 1% | 11.12 | 5 / 459 | 5% | 0.32 | 53 / 1118 |
prostate | 4% | 39.09 | 9 / 245 | 0% | 0 | 0 / 502 |
adrenal gland | 0% | 3.13 | 1 / 258 | 3% | 0.54 | 7 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0014003 | Biological process | oligodendrocyte development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016540 | Biological process | protein autoprocessing |
GO_0035902 | Biological process | response to immobilization stress |
GO_0032286 | Biological process | central nervous system myelin maintenance |
GO_0022010 | Biological process | central nervous system myelination |
GO_0042220 | Biological process | response to cocaine |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0048714 | Biological process | positive regulation of oligodendrocyte differentiation |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0031643 | Biological process | positive regulation of myelination |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0008233 | Molecular function | peptidase activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
Gene name | MYRF |
Protein name | Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal] Myelin regulatory factor |
Synonyms | C11orf9 KIAA0954 MRF |
Description | FUNCTION: [Myelin regulatory factor]: Constitutes a precursor of the transcription factor. Mediates the autocatalytic cleavage that releases the Myelin regulatory factor, N-terminal component that specifically activates transcription of central nervous system (CNS) myelin genes . .; FUNCTION: [Myelin regulatory factor, C-terminal]: Membrane-bound part that has no transcription factor activity and remains attached to the endoplasmic reticulum membrane following cleavage. .; FUNCTION: [Myelin regulatory factor, N-terminal]: Transcription factor that specifically activates expression of myelin genes such as MBP, MOG, MAG, DUSP15 and PLP1 during oligodendrocyte (OL) maturation, thereby playing a central role in oligodendrocyte maturation and CNS myelination. Specifically recognizes and binds DNA sequence 5'-CTGGYAC-3' in the regulatory regions of myelin-specific genes and directly activates their expression. Not only required during oligodendrocyte differentiation but is also required on an ongoing basis for the maintenance of expression of myelin genes and for the maintenance of a mature, viable oligodendrocyte phenotype . . |
Accessions | ENST00000675345.1 A0A6Q8PFY9 A0A6Q8PFL7 ENST00000278836.10 [Q9Y2G1-1] ENST00000675319.1 Q9Y2G1 ENST00000675792.1 A0A6Q8PHM1 ENST00000265460.9 [Q9Y2G1-2] |